Related Experiment Video
Updated: May 2, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Complementary and alternative medicine for the allergist-immunologist: where do I start?
Renata J M Engler1, Catherine M With, Philip J Gregory
1Vaccine Healthcare Centers Network, Allergy-Immunology Department, Walter Reed Army Medical Center, Washington, DC, USA.
Physicians face challenges managing complementary and alternative medicine (CAM) information. A 10-step process and reliable databases like Natural Medicines Comprehensive Database can improve CAM consultations and patient safety.
Area of Science:
- Integrative Medicine
- Healthcare Management
- Patient Safety
Background:
- Complementary and alternative medicine (CAM) use is prevalent, with nearly 40% of patients using or considering CAM.
- Natural products, including herbals, are common CAM therapies, with over 5% of children using CAM for allergies like asthma.
- Physicians face significant challenges in managing CAM information due to its volume, quality, and associated liability risks.
Purpose of the Study:
- To provide physicians with a structured approach to CAM consultations.
- To address legal and logistical factors influencing CAM encounters.
- To highlight the need for improved information access and safety surveillance for CAM therapies.
Main Methods:
- A comprehensive review focusing on CAM consultation strategies.
- Presentation of a 10-step process for conducting CAM consultations and documentation.
- Emphasis on the critical role of high-quality information resources like the Natural Medicines Comprehensive Database.
Main Results:
- A 10-step process is outlined to guide physicians through CAM consultations.
- The importance of accessing specific efficacy and safety data for CAM products is emphasized.
- Limited understanding of serious adverse events associated with CAM necessitates improved surveillance.
Conclusions:
- Physicians require efficient tools and information to manage CAM consultations effectively.
- Enhanced safety surveillance and international information sharing are crucial for CAM therapies.
- The allergy-immunology specialty is uniquely positioned to advance CAM-related adverse event evaluation and research.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
07:10Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Related Concept Videos
Cross-reactivity
Allergic Reactions
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Tumor Immunotherapy
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: